Study calls for reviews of psychotropic medication use in elderly

September 13, 2012 in Medications

(Medical Xpress)—Regular clinical reviews of psychotropic medication should be established in all care homes to promote safe and effective prescribing to an at-risk population of elderly people, according to a new study by researchers at the University of Dundee and NHS Fife, published today in Age & Ageing, the scientific journal of the British Geriatrics Society.

The use of psychotropic drugs - such as antipsychotics and antidepressants - in older people has long been of concern, particularly among those who are in nursing homes. A recent UK Parliamentary report expressed concern that their `inappropriate use' in care homes was a 'means of controlling patients'. There have also been recommendations that there should be a reduction of use of antipsychotic drugs in older people with dementia across the UK.

The new study shows that approximately 1 in 6 older people receive at least one psychotropic medication in a 2-year period. The figure rises to 2 in 5 among nursing home residents.

However, the study found that the majority of psychotropic drugs used by nursing home residents were started prior to the patient being admitted, and for those who started antipsychotics just prior to admission it was more likely the person would continue to receive the drugs.

"This study presents a complex picture of the prescribing and use of these medicines," said Colin McCowan, Deputy Director of the Health Informatics Centre at the University of Dundee. "Psychotropic use is significantly higher in care home residents but they would seem to be initiated primarily before people are admitted.

"This may be evidence against the belief that initiation is largely driven by care home staff to make residents easier or more convenient to manage.

"There may be valid reasons for the initiation of these drugs but prolonged use of psychotropic medication in is not recommended and may cause harm. The key issue our study suggests is that there should be systematic medication reviews for patients on these drugs, to highlight drugs that may be discontinued if the reasons for their initial prescription are no longer valid."

The study compared the prescribing of psychotropic medications in Tayside for patients living in to patients living at home. It used data gathered over a two-year period.

Previous research has shown that many of the antipsychotics being prescribed to patients are likely to be having very little beneficial effect, and can be reduced and usually stopped.

Stella Clark, of Fife, said there were some promising signs in prescribing patterns but that national guidance still needed to be developed.

"We have recently seen data for the whole of England which showed a reduction in the prescription of antipsychotics to people with dementia," said Stella.

"This is a really important area of prescribing where changes can be made which will improve patient safety and there is a clear need for national guidance to be developed."

Provided by University of Dundee search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Merck ends development of Parkinson's disease drug

(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.

Medications created May 23, 2013 | popularity 1 / 5 (1) | comments 0

J&J expects 10-plus new drug applications by 2017

(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...

Medications created May 23, 2013 | popularity 5 / 5 (1) | comments 0

Experts favor US approval of Merck sleeping pill (Update)

An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.

Medications created May 22, 2013 | popularity not rated yet | comments 0

Glaxo, US partnering to develop new antibiotics

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

Medications created May 22, 2013 | popularity not rated yet | comments 0

Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine

The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...

Medications created May 22, 2013 | popularity not rated yet | comments 0


Engineered cytomegalovirus protects monkeys from HIV equivalent

(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...

Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

Hormone levels may provide key to understanding psychological disorders in women

Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.

Going live: Immune cell activation in multiple sclerosis

Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...

Driving and hands-free talking lead to spike in errors, study shows

Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.

Help at hand for people with schizophrenia

How can healthy people who hear voices help schizophrenics? Finding the answer for this is at the centre of research conducted at the University of Bergen.